ClearPoint Neuro
CLPT
76 hedge funds and large institutions have $102M invested in ClearPoint Neuro in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 9 closing their positions.
289% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 9
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
69% more call options, than puts
Call options by funds: $4M | Put options by funds: $2.37M
56% more capital invested
Capital invested by funds: $65.6M → $102M (+$36.5M)
52% more funds holding
Funds holding: 50 → 76 (+26)
10.81% more ownership
Funds ownership: 15.01% → 25.82% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$16M |
| 2 |
State Street
Boston,
Massachusetts
|
+$5.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.22M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.08M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.72M |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$963K |
| 3 |
HF
HRT Financial
New York
|
-$810K |
| 4 |
Morgan Stanley
New York
|
-$698K |
| 5 |
Renaissance Technologies
New York
|
-$539K |
CLPT Hedge Fund Activity: Q2 2021 in Review
76 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2021, worth a combined $102M — up 56% from $65.6M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new CLPT positions and 9 closed out — a net gain of 26 holders — while 20 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $16M. The largest seller was Millennium Management, cutting an estimated $2.72M.
- 76 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2021, up from 50 in Q1 2021.
- Funds reported $102M of ClearPoint Neuro stock for Q2 2021, up 56% quarter-over-quarter.
- 35 funds opened new ClearPoint Neuro positions in Q2 2021 and 9 closed out, a net change of +26 holders.
- The largest ClearPoint Neuro buyer in Q2 2021 was BlackRock, an estimated $16M added.
- The largest ClearPoint Neuro seller in Q2 2021 was Millennium Management, an estimated $2.72M sold.
Based on aggregated 13F filings for Q2 2021.